25
Views
24
CrossRef citations to date
0
Altmetric
Original Article

An Inhibitor of Cell Proliferation Associated with Adhesion Formation Is Suppressed by N,O-Carboxymethyl Chitosan

, , , &
Pages 105-113 | Received 05 Aug 1997, Accepted 16 Feb 1998, Published online: 09 Jul 2009
 

Abstract

Surgical adhesions are a major cause of morbidity and mortality. The ideal barrier agent will both minimize adhesions and provide a milieu for the regeneration of the mesothelium lining of the abdominal and thoracic cavities. N,O-Carboxymethylchitosan (NOCC), a derivation of chitin that markedly reduces adhesions, may function to modulate intracellular signals such as growth factors and cytokines in the inflammatory exudate. Since transforming growth factor-β is implicated in the fibrotic process, we investigated the possibility that NOCC's effects on adhesion formation reflects a modulation of TGF-β activity. Using a biological assay for inhibition of cell proliferation to detect TGF-β activity, we demonstrate that NOCC suppresses the levels of an inhibitor of cell proliferation released into serum and peritoneal exudates after ce-cal abrasion in the rat. However, this activity was distinct from known forms of TGF-β as determined using both TGF-β-neutralizing antisera and a TGF-β-resistant cell proliferation assay. Thus at least one potential effect of NOCC involves a mechanism distinct from TGF-β inhibition.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.